Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Querfeld

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Dermatology|July 3, 2016
Long-term follow-up and management of small and medium-sized CD4<sup>+</sup> T cell lymphoma and CD8<sup>+</sup> lymphoid proliferations of acral sites: a multicenter experiencePooja Virmani, Sarah Jawed, Patricia L Myskowski, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2012
Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphomaTarita O Thomas, Priya Agrawal, Joan Guitart, et al.
American Journal of Clinical Pathology|September 18, 2024
Epstein-Barr virus-positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literatureLori Soma, Liliana Crisan, Jack Reid, et al.
Biomedicines|February 25, 2023
Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell LymphomaTina Petrogiannis-Haliotis, Kevin Pehr, David Roberge, et al.
The Journal of Investigative Dermatology|March 2, 2023
Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell LymphomaZhen Han, Xiwei Wu, Hanjun Qin, et al.
The British Journal of Dermatology|February 23, 2022
Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcomeCosimo Di Raimondo, Belen Rubio-Gonzalez, Joycelynne Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2011
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteinsChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Pediatric Dermatology|August 15, 2017
Clinical Outcome and Prognosis of Young Patients with Mycosis FungoidesPooja Virmani, Laura Levin, Patricia L Myskowski, et al.
Journal of the American Academy of Dermatology|February 25, 2020
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational studyEllen J Kim, Larisa Geskin, Joan Guitart, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Dermatology|July 3, 2016
Long-term follow-up and management of small and medium-sized CD4<sup>+</sup> T cell lymphoma and CD8<sup>+</sup> lymphoid proliferations of acral sites: a multicenter experiencePooja Virmani, Sarah Jawed, Patricia L Myskowski, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2012
Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphomaTarita O Thomas, Priya Agrawal, Joan Guitart, et al.
American Journal of Clinical Pathology|September 18, 2024
Epstein-Barr virus-positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literatureLori Soma, Liliana Crisan, Jack Reid, et al.
Biomedicines|February 25, 2023
Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell LymphomaTina Petrogiannis-Haliotis, Kevin Pehr, David Roberge, et al.
The Journal of Investigative Dermatology|March 2, 2023
Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell LymphomaZhen Han, Xiwei Wu, Hanjun Qin, et al.
The British Journal of Dermatology|February 23, 2022
Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcomeCosimo Di Raimondo, Belen Rubio-Gonzalez, Joycelynne Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2011
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteinsChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Pediatric Dermatology|August 15, 2017
Clinical Outcome and Prognosis of Young Patients with Mycosis FungoidesPooja Virmani, Laura Levin, Patricia L Myskowski, et al.
Journal of the American Academy of Dermatology|February 25, 2020
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational studyEllen J Kim, Larisa Geskin, Joan Guitart, et al.
Pageof 14